Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International Journal of Oncology

• Publication date

  2007-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO.30.3.679PMID 17273769
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fenretinide: a p53-independent way to kill cancer cells.

  2005cited by this paper
• Cancer Statistics, 2005

  2005cited by this paper
• Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein.

  2005cited by this paper
• Mechanisms of resistance to TRAIL-induced apoptosis in cancer

  2005cited by this paper
• A Phase I Clinical and Pharmacokinetic Study of Fenretinide Combined with Paclitaxel and Cisplatin for Refractory Solid Tumors

  2005cited by this paper
• Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae.

  2005cited by this paper
• Induction of apoptosis in primary meningioma cultures by fenretinide.

  2005cited by this paper
• Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.

  2005cited by this paper
• Promoting apoptosis as a strategy for cancer drug discovery

  2005cited by this paper
• N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines

  2004cited by this paper
• Inducible Silencing of KILLER/DR5 In vivo Promotes Bioluminescent Colon Tumor Xenograft Growth and Confers Resistance to Chemotherapeutic Agent 5-Fluorouracil

  2004cited by this paper
• Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide.

  2004cited by this paper
• Molecular Mechanisms of Fenretinide‐Induced Apoptosis of Neuroblastoma Cells

  2004cited by this paper
• Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells

  2004cited by this paper
• Fenretinide: a prototype cancer prevention drug

  2003cited by this paper
• Analysis of the phenotypes of Jurkat clones with different TRAIL-sensitivities.

  2003cited by this paper
• 15-Deoxy-Delta(12,14)-prostaglandin J2 induces apoptosis through activation of the CHOP gene in HeLa cells.

  2003cited by this paper
• Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.

  2003cited by this paper
• Induction of GADD153 and Bak: novel molecular targets of fenretinide-induced apoptosis of neuroblastoma.

  2003cited by this paper
• GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma.

  2002cited by this paper
• Mechanism of fenretinide (4-HPR)-induced cell death

  2001cited by this paper
• Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL‐R2 gene1

  2001cited by this paper
• Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.

  2001cited by this paper
• Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site

  2000cited by this paper
• Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma.

  2000cited by this paper
• Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.

  2000cited by this paper
• FADD Is Required for DR4- and DR5-mediated Apoptosis

  2000cited by this paper
• Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugs

  2000cited by this paper
• Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest

  1999cited by this paper
• Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.

  1999cited by this paper
• Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

  1999cited by this paper
• Safety and antitumor activity of recombinant soluble Apo2 ligand.

  1999cited by this paper
• Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells.

  1999cited by this paper
• TRAIL causes cleavage of bid by caspase-8 and loss of mitochondrial membrane potential resulting in apoptosis in BJAB cells.

  1999cited by this paper
• FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis.

  1998cited by this paper
• Apoptotic pathways: the roads to ruin.

  1998cited by this paper
• TRAIL/Apo2L Activates c-Jun NH2-terminal Kinase (JNK) via Caspase-dependent and Caspase-independent Pathways*

  1998cited by this paper
• CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum.

  1998cited by this paper
• Transient Poly(ADP-ribosyl)ation of Nuclear Proteins and Role of Poly(ADP-ribose) Polymerase in the Early Stages of Apoptosis*

  1998cited by this paper
• Identification and Molecular Cloning of Two Novel Receptors for the Cytotoxic Ligand TRAIL*

  1997cited by this paper
• An antagonist decoy receptor and a death domain-containing receptor for TRAIL.

  1997cited by this paper
• KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene

  1997cited by this paper
• TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAIL

  1997cited by this paper
• Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.

  1997cited by this paper
• Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells

  1996cited by this paper
• Induction of the mammalian stress response gene GADD153 by oxidative stress: role of AP-1 element.

  1996cited by this paper
• Biological and clinical importance of the p53 tumor suppressor gene.

  1996cited by this paper
• 4-Hydroxyphenyl Retinamide Is a Highly Selective Activator of Retinoid Receptors*

  1996cited by this paper
• Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

  1994cited by this paper
• Regulation of the C/EBP-related gene gadd153 by glucose deprivation

  1993cited by this paper

• Identification of progression related LncRNAs in colorectal cancer aggressiveness

  2025cites this paper
• Antiproliferative and Morphological Effects of Fenretinide Lipid Nanosystems in Colon Adenocarcinoma Cells

  2024cites this paper
• The endoplasmic reticulum: Homeostasis and crosstalk in retinal health and disease.

  2023cites this paper
• Integrating Genome-Wide Association Studies and Gene Expression Profiles With Chemical-Genes Interaction Networks to Identify Chemicals Associated With Colorectal Cancer

  2020cites this paper
• Engineering and combining oncolytic measles virus for cancer therapy

  2020cites this paper
• JDP2 is directly regulated by ATF4 and modulates TRAIL sensitivity by suppressing the ATF4–DR5 axis

  2020cites this paper
• Elucidation for modulation of death receptor (DR) 5 to strengthen apoptotic signals in cancer cells

  2019cites this paper
• Natural and synthetic retinoids in preclinical colorectal cancer models.

  2019cites this paper
• Augmenter of liver regeneration: Essential for growth and beyond.

  2019cites this paper
• Inhibition of euchromatin histone‐lysine N‐methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor‐related apoptosis‐inducing ligand through reactive oxygen species‐mediated activating transcription factor 4‐C/EBP homologous protein‐death receptor 5 pathway activation

  2018cites this paper
• Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer

  2016cites this paper
• YM155 sensitizes triple‐negative breast cancer to membrane‐bound TRAIL through p38 MAPK‐ and CHOP‐mediated DR5 upregulation

  2015cites this paper
• Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro.

  2014influential citation
• A formulated red ginseng extract upregulates CHOP and increases TRAIL-mediated cytotoxicity in human hepatocellular carcinoma cells.

  2013cites this paper
• Combination effect of equol and TRAIL against human cervical cancer cells.

  2013cites this paper
• Targeting triple negative human breast cancer with omega-3 docosahexaenoic acid (DHA) and tocotrienol

  2013cites this paper
• Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer

  2012cites this paper
• Green tea: an effective synergist with anticancer drugs for tertiary cancer prevention.

  2012cites this paper
• Thiourea compound AW00178 sensitizes human H1299 lung carcinoma cells to TRAIL-mediated apoptosis.

  2012cites this paper
• Distinct roles of different forms of vitamin E in DHA-induced apoptosis in triple-negative breast cancer cells.

  2012cites this paper
• Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity

  2012cites this paper
• Aus der Klinik für Pädiatrie mit Schwerpunkt Onkologie und Hämatologie der Medizinischen Fakultät Charité – Universitätsmedizin Berlin DISSERTATION Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity

  2012cites this paper
• β-Elemene Piperazine Derivatives Induce Apoptosis in Human Leukemia Cells through Downregulation of c-FLIP and Generation of ROS

  2011cites this paper
• TRAIL contributes to the apoptotic effect of 13‐cis retinoic acid in human sebaceous gland cells

  2011cites this paper
• Raf-1 kinase inhibitor protein modulation of the cellular response to chemotherapeutic drugs and PDE5 inhibitors.

  2011cites this paper
• The peptidomimetic, 1-adamantyl-substituted, and flex-het classes of retinoid-derived molecules: structure-activity relationships and retinoid receptor-independent anticancer activities.

  2010cites this paper
• Cyclin‐dependent kinase inhibitor SU9516 enhances sensitivity to methotrexate in human T‐cell leukemia Jurkat cells

  2010cites this paper
• Dihydroorotate dehydrogenase is required for N-(4-hydroxyphenyl)retinamide-induced reactive oxygen species production and apoptosis.

  2010cites this paper
• Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours

  2010cites this paper
• Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer

  2010cites this paper
• Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1

  2010cites this paper
• “Combination-oriented molecular-targeting prevention” of cancer: a model involving the combination of TRAIL and a DR5 inducer

  2010cites this paper
• Liposome-mediated therapy of neuroblastoma.

  2009cites this paper
• Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma

  2009cites this paper
• Flavonoids from Eupatorium Odoratum with Death Receptor 5 Promoter Enhancing Activity.

  2009cites this paper
• Agents that Regulate DR5 and Sensitivity to TRAIL

  2008cites this paper
• Acetyl-keto-beta-boswellic acid induces apoptosis through a death receptor 5-mediated pathway in prostate cancer cells.

  2008cites this paper
• Modulation of death receptors by cancer therapeutic agents

  2008cites this paper
• Acetyl-Keto-B-Boswellic Acid Induces Apoptosis through a Death Receptor 5 – Mediated Pathway in Prostate Cancer Cells

  2008cites this paper
• CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells.

  2008cites this paper
• ABT-737 Induces Expression of the Death Receptor 5 and Sensitizes Human Cancer Cells to TRAIL-induced Apoptosis*

  2008cites this paper
• - Induced Caspase-8 Activation and Apoptosis in Metastatic Neuroblasts

  2008cites this paper